We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
–
AUM
$279M
AUM Growth
–
Cap. Flow
+$274M
Cap. Flow %
98.51%
Top 10 Hldgs %
63.97%
Holding
86
New
86
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$42.6M
2
XOM icon
ExxonMobil
XOM
+$27.8M
3
CELG
Celgene Corp
CELG
+$19.6M
4
UNP icon
Union Pacific
UNP
+$19.3M
5
MUR icon
Murphy Oil
MUR
+$17.8M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 35.4%
2 Energy 18.67%
3 Industrials 17.57%
4 Technology 7.65%
5 Materials 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$315B
$41.3M 14.81%
+768,380
New +$42.6M
XOM icon
2
ExxonMobil
XOM
$611B
$28.1M 10.09%
+336,046
New +$27.8M
UNP icon
3
Union Pacific
UNP
$179B
$21.5M 7.7%
+160,000
New +$19.3M
MUR icon
4
Murphy Oil
MUR
$5.28B
$19.9M 7.14%
+640,637
New +$17.8M
CELG
5
DELISTED
Celgene Corp
CELG
$18.1M 6.5%
+173,487
New +$19.6M
ROP icon
6
Roper Technologies
ROP
$36.6B
$11.3M 4.05%
+43,602
New +$11.2M
JPM icon
7
JPMorgan Chase
JPM
$907B
$10.7M 3.85%
+100,412
New +$10.2M
AME icon
8
Ametek
AME
$54.3B
$10.3M 3.68%
+141,654
New +$9.87M
TMO icon
9
Thermo Fisher Scientific
TMO
$198B
$9.88M 3.54%
+52,006
New +$9.96M
DEL
10
DELISTED
Deltic Timber
DEL
$7.23M 2.59%
+78,926
New +$7.23M
MON
11
DELISTED
Monsanto Co
MON
$7.03M 2.52%
+60,200
New +$7.16M
GILD icon
12
Gilead Sciences
GILD
$167B
$6.91M 2.48%
+96,500
New +$7.33M
PH icon
13
Parker-Hannifin
PH
$120B
$6.82M 2.45%
+34,151
New +$6.35M
AMT icon
14
American Tower
AMT
$79.2B
$5.71M 2.05%
+40,000
New +$5.71M
BA icon
15
Boeing
BA
$169B
$4.96M 1.78%
+16,801
New +$4.55M
MUSA icon
16
Murphy USA
MUSA
$11.4B
$4.3M 1.54%
+53,558
New +$4.05M
MSFT icon
17
Microsoft
MSFT
$2.93T
$4.12M 1.48%
+48,122
New +$3.95M
PFE icon
18
Pfizer
PFE
$143B
$3.78M 1.36%
+110,046
New +$3.75M
COO icon
19
Cooper Companies
COO
$14B
$3.49M 1.25%
+64,000
New +$3.74M
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.89M 1.04%
+32,400
New +$2.82M
SHPG
21
DELISTED
Shire pic
SHPG
$2.85M 1.02%
+18,386
New +$2.72M
AAPL icon
22
Apple
AAPL
$4.9T
$2.83M 1.02%
+66,932
New +$2.8M
PF
23
DELISTED
Pinnacle Foods, Inc.
PF
$2.83M 1.02%
+47,610
New +$2.68M
EOG icon
24
EOG Resources
EOG
$74.5B
$2.68M 0.96%
+24,873
New +$2.51M
IFF icon
25
International Flavors & Fragrances
IFF
$20B
$2.51M 0.9%
+16,466
New +$2.47M
1
2 3 4

Similar funds

SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.15B AUM 25.5% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
BCM
Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

Aristotle Atlantic Partners's Q4 2017 Portfolio in Review

Q4 2017 is the first quarter with a 13F filing on record for Aristotle Atlantic Partners, which disclosed 86 positions worth $279M. Its ten largest holdings account for 64% of the portfolio.

Its largest position is Merck: 768,380 shares worth $41.3M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, followed by Energy and Industrials.

  • Aristotle Atlantic Partners's largest Q4 2017 buy was Merck: 768,380 shares worth $41.3M.
  • Aristotle Atlantic Partners's ten largest holdings make up 64% of its $279M portfolio in Q4 2017.
  • Aristotle Atlantic Partners disclosed 86 positions in Q4 2017, its first 13F filing on record.

Based on Aristotle Atlantic Partners's 13F filing for Q4 2017, filed 14 Feb 2018.